Cross-linked chitosan matrix-based multiple-unit drug delivery systems

被引:7
作者
Chen, W.
Lu, Z.
Enslin, G.
Olivier, E.
Pillay, V.
Steenekamp, J.
Hamman, J.
机构
[1] Tshwane Univ Technol, Sch Pharm, ZA-0001 Pretoria, South Africa
[2] Univ Witwatersrand, Dept Pharm & Pharmacol, ZA-2193 Johannesburg, South Africa
[3] North West Univ, Sch Pharm, Dept Pharmaceut, ZA-2520 Potchefstroom, South Africa
关键词
chitosan; swellable matrix; multiple-unit system; controlled release; Eudragit;
D O I
10.1016/S1773-2247(06)50034-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Matrix-based multiple-unit drug delivery systems were manufactured by the compression of conventional and cross-linked chitosan into mini-matrices, which were then loaded into hard gelatin capsules. Three different types of mini-matrices were manufactured by direct compression of chitosan powder (not cross-linked), cross-linked chitosan microparticles or cross-linked chitosan granules and were characterized in terms of their physical properties such as hardness, friability, dimensions as well as their swelling and dissolution characteristics. The mini-matrices were film coated with Eudragit polymers (i.e. Eudragit L100, S100 and L100-55) to allow for drug release to start at different pH values. Several combinations of the coated mini-matrices were loaded into hard gelatin capsules to provide for rapid release as well as for delayed-onset sustained release from each multiple-unit drug delivery system. Release kinetics of the matrices consisting of cross-linked chitosan microparticles are presented as well as the in vitro release profiles of the multiple-unit drug delivery systems.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 26 条
[1]   Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J].
Agnihotri, SA ;
Mallikarjuna, NN ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :5-28
[2]   A NOVEL-APPROACH TO THE ORAL DELIVERY OF MICRO-PARTICLES OR NANOPARTICLES [J].
BODMEIER, R ;
CHEN, HG ;
PAERATAKUL, O .
PHARMACEUTICAL RESEARCH, 1989, 6 (05) :413-417
[3]  
Collett J., 2002, PHARM SCI DOSAGE FOR, P289
[4]  
Colombo, 2000, Pharm Sci Technol Today, V3, P198, DOI 10.1016/S1461-5347(00)00269-8
[5]   Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics [J].
Cox, PJ ;
Khan, KA ;
Munday, DL ;
Sujja-areevath, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 193 (01) :73-84
[6]   Chitosan: A unique polysaccharide for drug delivery [J].
Felt, O ;
Buri, P ;
Gurny, R .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (11) :979-993
[7]  
GENTA I, 2002, CHITOSAN PHARM CHEM, P11
[8]   Chitosan-based gastrointestinal delivery systems [J].
Hejazi, R ;
Amiji, M .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (02) :151-165
[9]  
KASHYAP N, 2004, DRUG DELIV TECHNOL, V4, P33
[10]  
KIBBE HA, 2000, HDB PHARM EXCIPIENTS, P102